You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美单日新增16.87万宗新冠确诊 疾按中心建议学校复课
阿思达克 01-29 16:01
美国新冠疫情稍见缓和。据约翰霍普金斯大学统计,美国截至西岸时间午夜(本港时间下午4时),累计新冠确诊25,766,735宗,单日新增168,675宗。累计死亡个案433,195宗,单日新增4,000宗。各州疫情方面,加州累计327.39万宗确诊,德克萨斯州累计233.03万宗确诊。佛罗里达、纽约及伊利诺伊州各累计168.76万、138.29万及111.64万宗确诊。

美国国家过敏和传染病研究所所长福奇,为美国疾控中心提出学校重开的建议辩护。认为必须尝试让学生回校。美国疾控中心认为在社交距离及口罩令强制实施下,学生应尽早回校上课。另外,美国佛蒙特州有数以百计剂Moderna疫苗因储存气温不当或须报废,目前正检视该等疫苗能否被使用。

以下为美国过去七日新冠疫情统计:

日期│累计确诊│单日新增确诊│累计死亡│单日新增死亡

1月28日(四)│25,766,735宗│+168,675宗│433,195宗│+4,000宗

1月27日(三)│25,598,060宗│+158,485宗│429,195宗│+3,979宗

1月26日(二)│25,439,575宗│+142,504宗│425,216宗│+4,087宗

1月25日(一)│25,297,071宗│+170,065宗│421,129宗│+1,914宗

1月24日(日)│25,127,006宗│+132,539宗│419,215宗│+1,786宗

1月23日(六)│24,994,467宗│+172,652宗│417,429宗│+3,322宗

1月22日(五)│24,821,815宗│+189,925宗│414,107宗│+3,758宗

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account